Skip to main content
. 2017 Jul 4;16(3):2477–2482. doi: 10.3892/mmr.2017.6918

Figure 4.

Figure 4.

Figure 4.

Figure 4.

Figure 4.

Figure 4.

LOXL2 expression in a mouse model of tubulointerstitial fibrosis. Compared with in (A) vehicle-treated control mice, (B) diffuse tubulointerstitial fibrosis was induced 4 weeks after intraperitoneal injection of folic acid in CD1 mice. (C) Immunohistochemistry analysis detected LOXL2 protein expression in the fibrous interstitium and infiltrating mononuclear cells (arrows) in folic acid-injected mice. (D) mRNA expression levels of LOXL2 were markedly increased in folic acid-injected mice compared with vehicle-treated mice. (E) Results of a western blot analysis detected a significant increase in LOXL2 protein expression in folic acid-injected mice. Magnification, ×400. *P<0.05. LOXL2, lysyl oxidase-like 2.